These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33983909)

  • 1. Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration.
    Cannas G; Dubreuil L; Fichez A; Gerfaud-Valentin M; Debard AL; Hot A
    Am J Case Rep; 2021 May; 22():e931107. PubMed ID: 33983909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-N and anti-Do
    Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
    Vlachaki E; Gavriilaki E; Kafantari K; Adamidou D; Tsitsikas D; Chasapopoulou E; Anagnostopoulos A; Tsapas A
    Hemoglobin; 2018; 42(5-6):339-341. PubMed ID: 30626228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
    Pirenne F; Bartolucci P; Habibi A
    Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
    Hannema SE; Brand A; van Meurs A; Smiers FJ
    Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jk
    El Alaoui K; Benghiat FS; Colard M
    J Hematol; 2022 Apr; 11(2):66-70. PubMed ID: 35573755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two serial events of delayed hemolytic transfusion reactions due to different primary immune response-induced irregular antibodies].
    Mizuno K; Yamazaki R; Uemura T; Koda Y; Kikuchi T; Mori T
    Rinsho Ketsueki; 2020; 61(10):1482-1486. PubMed ID: 33162444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
    Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
    Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.
    Boonyasampant M; Weitz IC; Kay B; Boonchalermvichian C; Liebman HA; Shulman IA
    Transfusion; 2015 Oct; 55(10):2398-403. PubMed ID: 25989361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhaemolytic transfusion reaction in two β-thalassaemia major patients: The role of eculizumab.
    Pantelidou D; Pilalas D; Daios S; Polychronopoulos G; Papadopoulou D; Perifanis V; Savopoulos C; Kaiafa G
    J Clin Pharm Ther; 2022 Mar; 47(3):411-414. PubMed ID: 34397109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia.
    Bezirgiannidou Z; Christoforidou A; Kontekaki E; Anastasiadis AG; Papamichos SI; Menexidou H; Margaritis D; Martinis G; Mantadakis E
    Mediterr J Hematol Infect Dis; 2016; 8(1):e2016053. PubMed ID: 27872733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review.
    Vasanthamohan L; Choo S; Marshall T; Symons YT; Matsui D; Eastabrook G; Solh Z
    Transfusion; 2020 Oct; 60(10):2448-2455. PubMed ID: 32851670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
    Jajosky RP; Lumm WC; Wise SC; Bollag RJ; Shikle JF
    Immunohematology; 2017 Jun; 33(2):73-75. PubMed ID: 28657766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three episodes of delayed hemolytic transfusion reactions due to multiple red cell antibodies, anti-Di, anti-Jk and anti-E.
    Yasuda H; Ohto H; Yamaguchi O; Sakuma S; Suzuki T; Mita M; Tsuneyama H; Uchikawa M
    Transfus Sci; 2000 Oct; 23(2):107-12. PubMed ID: 11035271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.
    Ibanez C; Habibi A; Mekontso-Dessap A; Chadebech P; Chami B; Bierling P; Galactéros F; Rieux C; Nataf J; Bartolucci P; Peyrard T; Pirenne F
    Transfusion; 2016 Jul; 56(7):1828-33. PubMed ID: 27145018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Hyperhemolysis in β-thalassemia With Multiple Immunosuppressives, Including Complement Blockade.
    Zanetti RC; Vasta LM; Romanelli K; Newton TC
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1145-e1147. PubMed ID: 33480648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.